Christophe Willekens
0000-0001-9814-8537
Gustave Roussy
5 papers found
Refreshing results…
Enasidenib for the treatment of relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase 2 mutation
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study
Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Missing publications? Search for publications with a matching author name.